A Delaware federal court officially ended UroGen Pharma Ltd.'s patent infringement suit against Teva Pharmaceuticals Inc. pursuant to the parties’ stipulation of dismissal.

Texas will likely prevail in defending a law requiring proof of age to download a smart phone app, a federal appeals court ruled Thursday, lifting a trial court injunction that halted the law on First Amendment grounds.

Life Spine Inc. persuaded the Federal Circuit to invalidate the last challenged claims of a Globus Medical Inc. spinal-implant patent after the appeals court rejected a narrower interpretation of the invention.

AbbVie suffered another defeat in its bid to block a Mississippi law regulating how drug companies contract with pharmacies in the state under the federal drug discount program.

Thomas Health System Inc. and others defeated a whistleblower’s attempt to reinstate a False Claims Act suit alleging improper physician referrals, the Fourth Circuit said Thursday.

The US Supreme Court raised the bar for branded pharmaceutical companies seeking to sue over a competitor’s generic versions of their drugs that are marketed using what’s called a skinny label.